This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Informatics/ Internet in Medicine  • Internet  • Medical Practice  • Medical Ethics  • Statistics and Research Methods  • Drug Therapy  • Drug Therapy, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

Bridget M. Kuehn

JAMA. 2008;299(23):2733-2734.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Pharmaceutical companies are outsourcing the recruitment of patients for some clinical trials to companies that use Web sites for the purpose of collecting personal and medical data on prospective participants and screening them for suitability. But some critics of the practice are concerned that the tactics being used may put patient privacy or the integrity of clinical research at risk.

Traditionally, patients have been recruited for clinical trials through their physicians or via advertisements that direct them to contact the clinicians conducting the trial. More recently, Web sites that simply list or advertise clinical trials have become a common recruitment tool for both privately and publicly funded clinical trials.

But a drive by pharmaceutical companies to reduce costs, test more experimental drugs, and speed the development process has encouraged more aggressive strategies for patient recruitment. In this environment, an "industry" devoted to patient recruitment has emerged, fueled . . . [Full Text of this Article]

SELLING PATIENT DATA



CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?